Published in Clin Chem on July 01, 1974
A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Sci Technol (2010) 3.01
Investigation of 2 models to set and evaluate quality targets for hb a1c: biological variation and sigma-metrics. Clin Chem (2015) 1.64
Lipemia: causes, interference mechanisms, detection and management. Biochem Med (Zagreb) (2014) 1.17
Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers (2008) 1.08
Revised system to evaluate measurement of blood chemistry data from the Japanese National Health and Nutrition Survey and Prefectural Health and Nutrition Surveys. J Epidemiol (2012) 0.94
The relationships between common measures of glucose meter performance. J Diabetes Sci Technol (2012) 0.91
The Danger of Using Total Error Models to Compare Glucose Meter Performance. J Diabetes Sci Technol (2014) 0.83
Scoring of chest CT in children with cystic fibrosis: state of the art. Pediatr Radiol (2014) 0.81
Comparative Analysis of Urinary Total Proteins by Bicinchoninic Acid and Pyrogallol Red Molybdate Methods. J Clin Diagn Res (2015) 0.79
Fundamental issues in clinical chemistry. Am J Pathol (1979) 0.76
Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents. Biochem Med (Zagreb) (2012) 0.75
An Automated Homogeneous Immunoassay for Quantitating Imatinib Concentrations in Plasma. Ther Drug Monit (2015) 0.75
Assays of serum aminoglycoside levels by BACTEC 460 in the presence of cefamandole and cefoxitin. Antimicrob Agents Chemother (1981) 0.75
Quality control in clinical chemistry. Proc R Soc Med (1975) 0.75
Variation and the spice of life. Am J Clin Nutr (2016) 0.75
Vejle Diabetes Biobank - a resource for studies of the etiologies of diabetes and its comorbidities. Clin Epidemiol (2016) 0.75
A Validation Study of After Reconstitution Stability of Diabetes: Level 1 and Diabetes Level 2 Controls. EJIFCC (2017) 0.75
A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem (1981) 5.36
Use and interpretation of common statistical tests in method-comparison studies. Clin Chem (1973) 3.11
New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem (1998) 2.29
Adult onset grape hypersensitivity causing life threatening anaphylaxis. Ann Allergy Asthma Immunol (1999) 2.18
Peptide quantitative structure-activity relationships, a multivariate approach. J Med Chem (1987) 1.75
Combined Shewhart-cusum control chart for improved quality control in clinical chemistry. Clin Chem (1977) 1.44
Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP clinical and analytical goals. Clin Chem (1997) 1.39
Signal peptide amino acid sequences in Escherichia coli contain information related to final protein localization. A multivariate data analysis. EMBO J (1987) 1.34
Power functions for statistical control rules. Clin Chem (1979) 1.23
Concepts and practices in the evaluation of clinical chemistry methods. III: Statistics. Am J Med Technol (1978) 1.15
Performance characteristics of rules for internal quality control: probabilities for false rejection and error detection. Clin Chem (1977) 1.14
A multivariate study of the relationship between the genetic code and the physical-chemical properties of amino acids. J Mol Evol (1985) 1.12
Classification of fungi by means of pyrolysis-gas chromatography-pattern recognition. J Chromatogr (1979) 1.08
Selection of medically useful quality-control procedures for individual tests done in a multitest analytical system. Clin Chem (1990) 1.08
Trend detection in control data: optimization and interpretation of Trigg's technique for trend analysis. Clin Chem (1975) 1.06
Multivariate data analysis and experimental design in biomedical research. Prog Med Chem (1988) 1.04
Determination of serum albumin with the "SMA 12-60" by a bromcresol green dye-binding method. Clin Chem (1972) 1.03
Quantitative sequence-activity models (QSAM)--tools for sequence design. Nucleic Acids Res (1993) 1.02
Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. Int J Pept Protein Res (1991) 1.00
Assessment of "Average of Normals" quality control procedures and guidelines for implementation. Am J Clin Pathol (1984) 0.99
Fit of some analytical functions to insulin radio-immunoassay standard curves. Biochem J (1970) 0.97
Alignment of flexible molecules at their receptor site using 3D descriptors and Hi-PCA. J Comput Aided Mol Des (1997) 0.95
Statistical molecular design of building blocks for combinatorial chemistry. J Med Chem (2000) 0.94
Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles. Comput Biomed Res (1984) 0.93
The speed of the Escherichia coli fork in vivo depends on the DnaB:DnaC ratio. Mol Microbiol (1995) 0.93
Points of care in using statistics in method comparison studies. Clin Chem (1998) 0.91
An assessment of carcinogenicity of N-nitroso compounds by the SIMCA method of pattern recognition. J Chem Inf Comput Sci (1981) 0.90
Statistical molecular design of peptoid libraries. Mol Divers (1999) 0.90
A structure-carcinogenicity study of 4-nitroquinoline 1-oxides using the SIMCA method of pattern recognition. J Med Chem (1978) 0.90
Carcinogenicity of polycyclic aromatic hydrocarbons studied by SIMCA pattern recognition. Acta Chem Scand B (1978) 0.89
Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol (1995) 0.89
Comparison of results from the Du Pont "ACA" and Technicon "SMA 12-60". Clin Chem (1972) 0.88
Classification of human cancer cells by means of capillary gas chromatography and pattern recognition analysis. J Chromatogr (1981) 0.88
Uranium colloid analysis by single particle inductively coupled plasma-mass spectrometry. Talanta (2005) 0.87
Structure-activity study of beta-adrenergic agents using the SIMCA method of pattern recognition. J Med Chem (1978) 0.86
Use of the Du Pont "automatic clinical analyzer" in direct determination of lactic acid in plasma stabilized with sodium fluoride. Clin Chem (1972) 0.86
Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors. J Med Chem (2001) 0.86
Precision and accuracy: concepts and assessment by method evaluation testing. Crit Rev Clin Lab Sci (1981) 0.86
Implementation of a multirule, multistage quality control program in a clinical laboratory computer system. J Med Syst (1987) 0.85
Design and evaluation of statistical control procedures: applications of a computer "quality control simulator" program. Clin Chem (1981) 0.84
Contribution of arterial blood lactate measurement to the care of critically ill patients. Am J Clin Pathol (1977) 0.84
The prediction of bradykinin potentiating potency of pentapeptides. An example of a peptide quantitative structure-activity relationship. Acta Chem Scand B (1986) 0.84
Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs to human serum albumin. J Pharm Sci (1976) 0.83
Reproducibility of pyrolysis-gas chromatographic analyses of the mould Penicillium brevi-compactum. J Chromatogr (1979) 0.82
Adding value to proficiency testing programs. Clin Chem (2000) 0.82
Computer methods for the assessment of toxicity. Acta Pharmacol Toxicol (Copenh) (1983) 0.82
Quality control of multichannel hematology analyzers: evaluation of Bull's algorithm. Am J Clin Pathol (1985) 0.82
The Escherichia coli SeqA protein binds specifically to two sites in fully and hemimethylated oriC and has the capacity to inhibit DNA replication and affect chromosome topology. Biochimie (2001) 0.82
Plasma levels and clinical effects of thioridazine and thiothixene. J Clin Pharmacol (1975) 0.82
Concepts and practices in the evaluation of clinical chemistry methods. V. Applications. Am J Med Technol (1978) 0.81
Peptide QSAR on substance P analogues, enkephalins and bradykinins containing L- and D-amino acids. Acta Chem Scand (1990) 0.81
Structure-activity analyzed by pattern recognition: the asymmetric case. J Med Chem (1980) 0.81
Application of an automated determination of isoenzyme-5 of lactage dehydrogenase to the diagnosis of hepatic disease. Clin Chem (1973) 0.80
Classification of polychlorinated biphenyl residues: isomers vs. homologue concentrations in modeling aroclors and polychlorinated biphenyl residues. Anal Chem (1987) 0.80
A multivariate representation and analysis of DNA sequence data. Acta Chem Scand (1991) 0.80
Analytical goal-setting for monitoring patients when two analytical methods are used. Clin Chem (1992) 0.80
A candidate reference method for determination of total protein in serum. II. Test for transferability. Clin Chem (1981) 0.79
Field evaluation of the Becton-Dickinson SST. Health Lab Sci (1976) 0.79
Statistical analysis of method comparison data. Testing normality. Am J Clin Pathol (1979) 0.79
Three-block bi-focal PLS (3BIF-PLS) and its application in QSAR. SAR QSAR Environ Res (2005) 0.79
Principal component analysis: an alternative to "referee" methods in method comparison studies. Anal Chem (1975) 0.79
Development of mechanisms underlying spatial perspectives. Child Dev (1974) 0.79
The formation of ES of cytochrome-c peroxidase: a comparison with lactoperoxidase and horseradish peroxidase. Biochim Biophys Acta (1986) 0.78
Bacterial two-component signalling as a therapeutic target in drug design. Inhibition of NRII by the diphenolic methanes (bisphenols). Adv Exp Med Biol (1998) 0.78
Trace-element concentrations in blood samples from welders of stainless steel or aluminium and a reference group. Scand J Work Environ Health (1977) 0.78
Selecting appropriate quality-control rules. Clin Chem (1994) 0.77
Influence of a between-run component of variation, choice of control limits, and shape of error distribution on the performance characteristics of rules for internal quality control. Clin Chem (1979) 0.77
Principal properties of aromatic substituents. Prog Clin Biol Res (1989) 0.76
Peptide QSARS: PLS modelling and design in principal properties. Prog Clin Biol Res (1989) 0.76
Models for combining random and systematic errors. assumptions and consequences for different models. Clin Chem Lab Med (2001) 0.76
Multivariate parametrization of coded and non-coded amino acids by thin layer chromatography. Prog Clin Biol Res (1989) 0.76
A multivariate pattern recognition study of risk-factors indicating postoperative thromboembolism despite low-dose heparin in major abdominal surgery. Thromb Haemost (1985) 0.76
Interpreting complicated chromatographic patterns. J Pharm Biomed Anal (1991) 0.76
A strategy for ranking environmentally occurring chemicals. Part VI. QSARs for the mutagenic effects of halogenated aliphatics. Acta Chem Scand (1991) 0.76
Distribution of arsenic, manganese, and selenium in the human brain in chronic renal insufficiency, Parkinson's disease, and amyotrophic lateral sclerosis. J Neurol Sci (1981) 0.75
Simulation and modeling for optimizing quality control and improving analytical quality assurance. Clin Chem (1992) 0.75
Toxicity modeling and prediction with pattern recognition. Environ Health Perspect (1985) 0.75
Quality control for qualitative assays: quantitative QC procedure designed to assure analytical quality required for an ELISA of hepatitis B surface antigen. Clin Chem (1997) 0.75
Albumin activation of urinary amylase as determined with the Du Pont aca. Clin Chem (1978) 0.75
Concepts and practices in the evaluation of clinical chemistry methods. I. Background and approach. Am J Med Technol (1978) 0.75
Performance studies on the Technicon "SMAC" analyzer: Precision and comparison of values with methods in routine laboratory service. Clin Chem (1976) 0.75
Assessment of a serum separator device for obtaining serum specimens suitable for clinical analyses. Clin Chem (1976) 0.75
Evaluation of the co-immobilized hexokinase/glucose-6-phosphate dehydrogenase method for glucose, as adapted to the Technicon SMAC. Clin Chem (1978) 0.75
Assessment of the serum separator tube as an intermediate storage device within the laboratory. Am J Clin Pathol (1976) 0.75
Concepts and practices in the evaluation of clinical chemistry methods. II. Experimental procedures. Am J Med Technol (1978) 0.75
Automated separation and measurement of lactate dehydrogenase isoenzymes. Clin Chem (1976) 0.75
Computer-controlled instrument system for sequential clinical chemical testing. I. Instrumentation and system features. Clin Chem (1973) 0.75
Letter: Separation of creatine kinase isoenzymes by high-pressure liquid chromatography. Clin Chem (1975) 0.75
Concepts and practices in the evaluation of clinical chemistry methods: IV. Decisions of acceptability. Am J Med Technol (1978) 0.75